A panel of top scientists is urging the Obama administration to bet big on tumor profiling and immunotherapy treatments in its cancer moonshot—two areas that are viewed with great promise, but still face unanswered questions about their ultimate effectiveness.
A panel of top scientists is urging the Obama administration to bet big on tumor profiling and immunotherapy treatments in its cancer moonshot-two areas that are viewed with great promise, but still face unanswered questions about their ultimate effectiveness. The experts are recommending the creation of a new national network that would allow cancer patients across the country to have their tumors genetically profiled and included in a new national database-one of several recommended steps that they say would significantly speed the progress of cancer research in the United States. The panel is also urging the creation of a network to coordinate clinical trials using immunotherapy, the promising new treatment that turns the body’s immune system against the disease. The recommendations are part of a formal report issued Wednesday by an expert panel advising the White House in its cancer moonshot initiative.